GAP43 accelerates the malignant development of thyroid cancer cells through epithelial-mesenchymal transition (Zheng et al., 2019) and GAP43 was also reported to be associated with metastasis promotion in lung cancer (Zhang et al., 2018). This evidence concerns the gene GAP43 and thyroid gland carcinoma.